GRI Bio, Inc.
GRI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $22,538 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $11,628 | $0 | $0 | $0 |
| Gross Profit | $10,910 | $0 | $0 | $0 |
| % Margin | 48.4% | – | – | – |
| R&D Expenses | $3,768 | $3,232 | $242 | $249 |
| G&A Expenses | $4,467 | $8,155 | $1,997 | $813 |
| SG&A Expenses | $4,467 | $8,155 | $1,997 | $813 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8,235 | $11,387 | $2,239 | $1,062 |
| Operating Income | -$8,235 | -$11,387 | -$2,239 | -$1,062 |
| % Margin | -36.5% | – | – | – |
| Other Income/Exp. Net | $28 | -$1,650 | -$978 | -$497 |
| Pre-Tax Income | -$8,207 | -$13,037 | -$3,217 | -$1,559 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8,207 | -$13,037 | -$3,217 | -$1,559 |
| % Margin | -36.4% | – | – | – |
| EPS | -55.21 | -6,242.18 | -165,346 | -815.8 |
| % Growth | 99.1% | 96.2% | -20,168% | – |
| EPS Diluted | -55.21 | -6,242.18 | -165,346 | -815.8 |
| Weighted Avg Shares Out | 183 | 44 | 32 | 325 |
| Weighted Avg Shares Out Dil | 183 | 44 | 32 | 325 |
| Supplemental Information | – | – | – | – |
| Interest Income | $25 | $0 | $0 | $0 |
| Interest Expense | $0 | $2,082 | $653 | $547 |
| Depreciation & Amortization | $4 | $57 | $50 | $73 |
| EBITDA | -$8,231 | -$10,898 | -$2,514 | -$939 |
| % Margin | -36.5% | – | – | – |